These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35049068)

  • 1. Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin.
    Lindh C; Samaratunga H; Delahunt B; Bergström R; Chellappa V; Yaxley J; Lindberg J; Egevad L
    Prostate; 2022 Apr; 82(5):576-583. PubMed ID: 35049068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
    Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
    Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
    Lotan TL; Toubaji A; Albadine R; Latour M; Herawi M; Meeker AK; DeMarzo AM; Platz EA; Epstein JI; Netto GJ
    Mod Pathol; 2009 Mar; 22(3):359-65. PubMed ID: 19151660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
    Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
    Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
    Kaur HB; Salles DC; Paulk A; Epstein JI; Eshleman JR; Lotan TL
    Histopathology; 2021 Jan; 78(2):327-333. PubMed ID: 32740981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
    Amin A; Epstein JI
    Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
    Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
    Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
    Sanati S; Watson MA; Salavaggione AL; Humphrey PA
    Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIN-like (Ductal) Adenocarcinoma of the Prostate.
    Paulk A; Giannico G; Epstein JI
    Am J Surg Pathol; 2018 Dec; 42(12):1693-1700. PubMed ID: 30138215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Origin and Tumor Heterogeneity of Prostatic Ductal Adenocarcinoma in the Han Chinese Population.
    Zhang W; Su F; Wang M; Hou H; Liu M; Liu D; Liu H
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):727-732. PubMed ID: 34788144
    [No Abstract]   [Full Text] [Related]  

  • 13. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
    Romero-Rojas AE; Diaz-Perez JA; Reddy A
    Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
    Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
    J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
    Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
    Samaratunga H; Duffy D; Yaxley J; Delahunt B
    Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.
    Iakymenko OA; Lugo I; Kwon D; Zhao W; Hayee A; Punnen S; Parekh DJ; Pollack A; Ritch CR; Gonzalgo ML; Stoyanova R; Jorda M; Kryvenko ON
    Urology; 2020 Mar; 137():108-114. PubMed ID: 31711982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
    Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
    J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
    Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
    Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and EZH2, ERG and SPINK1 protein expression in pure and mixed ductal adenocarcinoma of the prostate.
    Patil PA; McKenney JK; Reynolds JP; Przybycin CG; Magi-Galluzzi C
    Histol Histopathol; 2019 Apr; 34(4):381-390. PubMed ID: 30246858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.